anonymous
Guest
anonymous
Guest
Everyone knew that 3 reps in a territory selling Vraylar or Ubrelvy was too much. You were told over and over again and many in management agreed but did nothing. Now we're seeing the reality of how insane it is and a complete waste of money. Renner said he was in charge of this and it was his decision. This move shows he has zero clue about the field and access and what works for the providers. Please.... someone in Abbvie (not Allergan) get rid of this guy. He just wasted a dump truck full of cash..